Other
Amount that if recognized, would affect the effective tax rate or regulatory liability
Raymond James Financial Amount that if recognized, would affect the effective tax rate or regulatory liability remained flat by 0.0% to $41M in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $41M to $41M. Over 5 years (FY 2020 to FY 2025), Amount that if recognized, would affect the effective tax rate or regulatory liability shows relatively stable performance with a 0.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2014
Last reportedQ4 2025Nov 25, 2025
Metric ID:
other_unrecognized_tax_benefits_that_would_impact_effect_ff36cbHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $31M | $38M | $35M | $41M | $41M |
| QoQ Change | — | +22.6% | -7.9% | +17.1% | +0.0% |
| YoY Change | — | +22.6% | -7.9% | +17.1% | +0.0% |
Range$31M – $41M
CAGR+32.3%
Avg YoY Growth+8.0%
Median YoY Growth+8.6%
Current Streak2 quarters growth
Amount that if recognized, would affect the effective tax rate or regulatory liability at Other Companies
Frequently Asked Questions
- What is Raymond James Financial's amount that if recognized, would affect the effective tax rate or regulatory liability?
- Raymond James Financial (RJF) reported amount that if recognized, would affect the effective tax rate or regulatory liability of $41M in Q3 2025.
- How has Raymond James Financial's amount that if recognized, would affect the effective tax rate or regulatory liability changed year-over-year?
- Raymond James Financial's amount that if recognized, would affect the effective tax rate or regulatory liability decreased by 0.0% year-over-year, from $41M to $41M.
- What is the long-term trend for Raymond James Financial's amount that if recognized, would affect the effective tax rate or regulatory liability?
- Over 5 years (2020 to 2025), Raymond James Financial's amount that if recognized, would affect the effective tax rate or regulatory liability has grown at a 0.5% compound annual growth rate (CAGR), from $40M to $41M.